title: Comparative activity of oral beta-lactam antibiotics at clinically achievable levels against Haemophilus influenzae serotype b.
authors.forename: C
authors.initials: C
authors.lastname: Doit
authors.forename: S
authors.initials: S
authors.lastname: Conort-Valentin
authors.forename: C
authors.initials: C
authors.lastname: Sanchez
authors.forename: P
authors.initials: P
authors.lastname: Mariani-Kurkdjian
authors.forename: E
authors.initials: E
authors.lastname: Bingen
mesh_terms: D000284:Administration, Oral; D000658:Amoxicillin / Q000494:pharmacology; D019980:Amoxicillin-Potassium Clavulanate Combination; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002969:Clavulanic Acids / Q000494:pharmacology; D004359:Drug Therapy, Combination / Q000494:pharmacology; D006193:Haemophilus influenzae / Q000145:classification / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D008826:Microbial Sensitivity Tests; D001618:beta-Lactamases / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D002969:Clavulanic Acids; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; D001618:beta-Lactamases